Real-time enrollment status for this vulvar cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 4:50 AM UTC
| NCT Number | NCT06075264 |
| Recruiting Status | Recruiting |
| Condition | Vulvar Cancer |
| Phase | PHASE2 |
| Target Enrollment | 27 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Frantz Viral Therapeutics, LLC |
| Last Updated on CT.gov | August 14, 2025 (Aug 14, 2025) |
As of August 29, 2026: Clinical trial NCT06075264 is currently recruiting participants. This phase2 study for vulvar cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Frantz Viral Therapeutics, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06075264 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06075264 was last updated Aug 14, 2025 (August 14, 2025). HelloStudys verifies this status automatically.